FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Katharina Buerger

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Phosphorylation

Physiology

Disease Progression

Procedures

Anatomy

Brain

Co-author Network

Publications

TOP 3
Richard Dodel; Martin Farlow; Stefan Förster; Jerome Goldstein; Stefan Haag; Michael Jacoby; Judith Alferink; Piero Antuono; Jan-Philipp Bach; Frederik Barkhof; Peter Bartenstein; Kaj Blennow; Katharina Buerger; Isaac Melamed; Markus Otto; Julius Popp; Ralph Richter; Axel Rominger; James Stevens; Stefan Wietek; Jens Wiltfang; Yaroslav Winter; Frank Jessen
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial.
Stefan J Teipel; Wolfgang Hoffmann; David Prvulovic; Osama Sabri; Henryk Barthel; Arun Bokde; Katharina Buerger; Michael Ewers; Michel Grothe; Harald Hampel
Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
Verena C Buschert; Ina Giegling; Harald Hampel; Sabrina Jolk; Dan Rujescu; Stefan J Teipel; Katharina Buerger
Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Katharina Buerger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard Dodel; Martin Farlow; Stefan Förster; Jerome Goldstein; Stefan Haag; Michael Jacoby; Judith Alferink; Piero Antuono; Jan-Philipp Bach; Frederik Barkhof; Peter Bartenstein; Kaj Blennow; Katharina Buerger; Isaac Melamed; Markus Otto; Julius Popp; Ralph Richter; Axel Rominger; James Stevens; Stefan Wietek; Jens Wiltfang; Yaroslav Winter; Frank Jessen
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial.
Lancet neurology 2013;12(3):233-43.
2013: Stefan J Teipel; Wolfgang Hoffmann; David Prvulovic; Osama Sabri; Henryk Barthel; Arun Bokde; Katharina Buerger; Michael Ewers; Michel Grothe; Harald Hampel
Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2013;33 Suppl 1():S329-47.
2012: Verena C Buschert; Ina Giegling; Harald Hampel; Sabrina Jolk; Dan Rujescu; Stefan J Teipel; Katharina Buerger
Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment.
The Journal of clinical psychiatry 2012;73(12):e1492-8.
2012: Michael Ewers; Yetunde O Faluyi; Annette Fitzpatrick; Harald Hampel; Oskar Hansson; Lennart Minthon; Susanne Schmitz; Leslie M Shaw; Stefan J Teipel; John Q Trojanowski; Bruno Vellas; Cathal Walsh; Michael Weiner; David Bennett; Kaj Blennow; Katharina Buerger; Bruno Dubois
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease.
Neurobiology of aging 2012;33(8):1599-608.
2012: Y Likitjaroen; Thomas Meindl; Katharina Buerger; U Friese; Harald Hampel; M Wagner; Stefan J Teipel
Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.
European archives of psychiatry and clinical neuroscience 2012;262(4):341-50.
2011: Philine Schneider; Stefan J Teipel; Olga Uspenskaya; Henrik Zetterberg; Andreas Bergmann; Kaj Blennow; Katharina Buerger; Andrea Ernst; Oskar Hansson; Oliver Hartmann; Lennart Minthon; Hans-Juergen Moeller; Dan Rujescu; Harald Hampel
Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment.
Biological psychiatry 2011;70(2):145-51.
2011: Katharina Buerger; Olga Uspenskaya; Oliver Hartmann; Oskar Hansson; Lennart Minthon; Kaj Blennow; Hans-Juergen Moeller; Stefan J Teipel; Andrea Ernst; Andreas Bergmann; Harald Hampel
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment.
The Journal of clinical psychiatry 2011;72(4):556-63.
2011: Stefan Förster; Uwe Friese; Harald Hampel; Stefan J Teipel; Peter Bartenstein; Hans-Georg Buchholz; Verena C Buschert; Alexander Drzezga; Katharina Buerger
Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2011;26 Suppl 3():337-48.
2011: Stefan Förster; Uwe Friese; Harald Hampel; Christian la Fougere; Axel Rominger; Stefan J Teipel; Christian Zach; Peter Bartenstein; Hans-Georg Buchholz; Verena C Buschert; Alexander Drzezga; Katharina Buerger
Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2011;25(4):695-706.
2011: Verena C Buschert; Uwe Friese; Harald Hampel; Wibke Merensky; Hans-Jürgen Möller; Dan Rujescu; Philine Schneider; Stefan J Teipel; Katharina Buerger
Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
Journal of Alzheimer's disease : JAD 2011;25(4):679-94.
2011: Michael Ewers; Katharina Buerger; Xin Cheng; Ping He; Thomas Meindl; Hikmet F Nural; Yong Shen; Stefan J Teipel; Cathal Walsh; Zhenyu Zhong; Harald Hampel
Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2011;25(2):373-81.
2010: W Koch; Stefan J Teipel; S Mueller; Katharina Buerger; Arun Bokde; Harald Hampel; U Coates; Maximilian Reiser; Thomas Meindl
Effects of aging on default mode network activity in resting state fMRI: does the method of analysis matter?
NeuroImage 2010;51(1):280-7.
2010: Stefan Förster; Andreas Vaitl; Stefan J Teipel; Igor Yakushev; Mona Mustafa; Christian la Fougère; Axel Rominger; Paul Cumming; Peter Bartenstein; Harald Hampel; Thomas Hummel; Katharina Buerger; Walter Hundt; Silke Steinbach
Functional representation of olfactory impairment in early Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2010;22(2):581-91.
2009: Katharina Buerger; Giovanni B Frisoni; Olga Uspenskaya; Michael Ewers; Henrik Zetterberg; Cristina Geroldi; Giuliano Binetti; Peter Johannsen; Paolo Maria Rossini; Lars-Olof Wahlund; Bruno Vellas; Kaj Blennow; Harald Hampel
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
Experimental gerontology 2009;44(9):579-85.
2009: Katharina Buerger; Andrea Ernst; Michael Ewers; Olga Uspenskaya; Muamer Omerovic; Nils G. Morgenthaler; Katharina Knauer; Andreas Bergmann; Harald Hampel
Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
Biological psychiatry 2009;65(11):979-84.
2009: Philine Schneider; Harald Hampel; Katharina Buerger
Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.
CNS neuroscience & therapeutics 2009;15(4):358-74.
2008: Muamer Omerovic; Harald Hampel; Stefan J Teipel; Katharina Buerger
Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2008;9(1):69-75.
2007: Michael Ewers; Katharina Buerger; Stefan J Teipel; Philip scheltens; J Schröder; Raymond Zinkowski; Femke H Bouwman; Peter Schönknecht; Niki S M Schoonenboom; Niels Andreasen; Anders Wallin; John DeBernardis; Daniel Kerkman; Bernhard Heindl; Kaj Blennow; Harald Hampel
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.
Neurology 2007;69(24):2205-12.
2007: Katharina Buerger; Irina Alafuzoff; Michael Ewers; Tuula Pirttilä; Raymond Zinkowski; Harald Hampel
No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease.
Brain : a journal of neurology 2007;130(Pt 10):e82.
2007: Andrea Ernst; Nils G. Morgenthaler; Katharina Buerger; Richard Dodel; Carmen Noelker; Norbert Sommer; Markus Schwarz; Josef Koehrle; Andreas Bergmann; Harald Hampel
Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation.
Journal of neuroimmunology 2007;189(1-2):169-74.
2006: Katharina Buerger; Michael Ewers; Tuula Pirttilä; Raymond Zinkowski; Irina Alafuzoff; Stefan J Teipel; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Hilkka Soininen; Harald Hampel
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Brain : a journal of neurology 2006;129(Pt 11):3035-41.
2006: Katharina Buerger; Markus Otto; Stefan J Teipel; Raymond Zinkowski; Kaj Blennow; John DeBernardis; Daniel Kerkman; Johannes Schröder; Peter Schönknecht; Lukas Cepek; Cheryl McCulloch; Hans-Jürgen Möller; Jens Wiltfang; Hans A Kretzschmar; Harald Hampel
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Neurobiology of aging 2006;27(1):10-5.
2005: Katharina Buerger; Stefan J Teipel; Raymond Zinkowski; Trey Sunderland; Niels Andreasen; Kaj Blennow; Michael Ewers; John DeBernardis; Yong Shen; Daniel Kerkman; Yansheng Du; Harald Hampel
Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment.
Neuroscience letters 2005;391(1-2):48-50.
2005: Katharina Buerger; Michael Ewers; Niels Andreasen; Raymond Zinkowski; K Ishiguro; Eugeen Vanmechelen; Stefan J Teipel; Christian Graz; Kaj Blennow; Harald Hampel
Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study.
Neurology 2005;65(9):1502-3.
2005: Arun Bokde; Stefan J Teipel; Robert Schwarz; Gerda Leinsinger; Katharina Buerger; Tobias Moeller; Hans-Jürgen Möller; Harald Hampel
Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects.
Brain research. Brain research protocols 2005;14(3):135-45.
2005: Annica Johansson; Henrik Zetterberg; Harald Hampel; Katharina Buerger; Jonathan A Prince; Lennart Minthon; Lars-Olof Wahlund; Kaj Blennow
Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2005;20(6):367-74.
2004: Harald Hampel; Stefan J Teipel; T Fuchsberger; Niels Andreasen; J Wiltfang; M Otto; Yong Shen; Richard Dodel; Yansheng Du; Martin R Farlow; Hans-Jürgen Möller; Kaj Blennow; Katharina Buerger
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Molecular psychiatry 2004;9(7):705-10.
2004: Harald Hampel; Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Alexander Goernitz; Niels Andreasen; Magnus Sjoegren; John DeBernardis; Daniel Kerkman; Koichi Ishiguro; Hideto Ohno; Eugeen Vanmechelen; hugo vanderstichele; Cheryl McCulloch; Hans-Jurgen Moller; Peter Davies; Kaj Blennow
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Archives of general psychiatry 2004;61(1):95-102.
2003: Annika Olsson; Kina Höglund; Magnus Sjögren; Niels Andreasen; Lennart Minthon; Lars Lannfelt; Katharina Buerger; Hans-Jürgen Möller; Harald Hampel; Pia Davidsson; Kaj Blennow
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
Experimental neurology 2003;183(1):74-80.
2003: Harald Hampel; Alexander Goernitz; Katharina Buerger
Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein.
Brain research bulletin 2003;61(3):243-53.
2003: Jens Wiltfang; Hermann Esselmann; Alexandr Smirnov; Mirko Bibl; Lukas Cepek; Petra Steinacker; Brit Mollenhauer; Katharina Buerger; Harald Hampel; Sabine Paul; Manuela Neumann; Manuel Maler; Inga Zerr; Johannes Kornhuber; Hans A Kretzschmar; Sigrid Poser; Markus Otto
Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Annals of neurology 2003;54(2):263-7.
2003: Annica Johansson; Harald Hampel; Frank Faltraco; Katharina Buerger; Lennart Minthon; Nenad Bogdanovic; M Sjögren; Henrik Zetterberg; L Forsell; L Lilius; Lars-Olof Wahlund; Lars Rymo; Jonathan A Prince; Kaj Blennow
Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia.
Neuroscience letters 2003;340(1):69-73.
2003: Peter Schönknecht; Johannes Pantel; Aoife Hunt; Martin Volkmann; Katharina Buerger; Harald Hampel; Johannes Schröder
Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease.
Neuroscience letters 2003;339(2):172-4.
2003: Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Hiroyuki Arai; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Frank Padberg; Frank Faltraco; Alexander Goernitz; Tero Tapiola; Stanley I Rapoport; Tuula Pirttilä; Hans-Jürgen Möller; Harald Hampel
Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.
The American journal of psychiatry 2003;160(2):376-9.
2002: Katharina Buerger; Stefan J Teipel; Raymond Zinkowski; Kaj Blennow; Hiroyuki Arai; Rolf Engel; Klaus Hofmann-Kiefer; Cheryl McCulloch; U Ptok; Reinhard Heun; Niels Andreasen; John DeBernardis; Daniel Kerkman; H- J Moeller; Peter Davies; Harald Hampel
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects.
Neurology 2002;59(4):627-9.
2002: Richard Dodel; Harald Hampel; Candan Depboylu; Suizhen Lin; Feng Gao; Sabine Schock; Steffi Jäckel; Xing Wei; Katharina Buerger; Christine Höft; Bernhard Hemmer; Hans-Jürgen Möller; Martin R Farlow; Wolfgang H Oertel; Norbert Sommer; Yansheng Du
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.
Annals of neurology 2002;52(2):253-6.
2002: Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Tero Tapiola; Hiroyuki Arai; Kaj Blennow; Niels Andreasen; Klaus Hofmann-Kiefer; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Russell Kohnken; Frank Padberg; Tuula Pirttilä; Mark B Schapiro; Stanley I Rapoport; Hans-Jürgen Möller; Peter Davies; Harald Hampel
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Archives of neurology 2002;59(8):1267-72.
2002: Arun Bokde; Stefan J Teipel; York Zebuhr; Gerda Leinsinger; L Gootjes; Robert Schwarz; Katharina Buerger; Philip scheltens; H- J Moeller; Harald Hampel
A new rapid landmark-based regional MRI segmentation method of the brain.
Journal of the neurological sciences 2002;194(1):35-40.
2001: Yansheng Du; Richard Dodel; Harald Hampel; Katharina Buerger; S Lin; BJ Eastwood; K Bales; Feng Gao; H- J Moeller; Wolfgang H Oertel; Martin R Farlow; S Paul
Reduced levels of amyloid beta-peptide antibody in Alzheimer disease.
Neurology 2001;57(5):801-5.
2001: N Itoh; Hiroyuki Arai; Katsuya Urakami; K Ishiguro; H Ohno; Harald Hampel; Katharina Buerger; J Wiltfang; M Otto; Hans A Kretzschmar; H- J Moeller; M Imagawa; H Kohno; K Nakashima; Shigeki Kuzuhara; Hidetada Sasaki; K Imahori
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease.
Annals of neurology 2001;50(2):150-6.
2001: Harald Hampel; Katharina Buerger; Russell Kohnken; Stefan J Teipel; Raymond Zinkowski; H- J Moeller; Stanley I Rapoport; Peter Davies
Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231.
Annals of neurology 2001;49(4):545-6.
2000: Russell Kohnken; Katharina Buerger; Raymond Zinkowski; C Miller; Daniel Kerkman; John DeBernardis; J Shen; Hans-Jürgen Möller; Peter Davies; Harald Hampel
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.
Neuroscience letters 2000;287(3):187-90.